(Q73515861)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704956%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

IV glycine and oral D-cycloserine effects on plasma and CSF amino acids in healthy humans (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704956%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

D C D'Souza

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704956%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

R Gil

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704956%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

K Cassello

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704956%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

K Morrissey

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704956%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

D Abi-Saab

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704956%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

J White

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704956%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

R Sturwold

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704956%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

A Bennett

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704956%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

L P Karper

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704956%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

E Zuzarte

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704956%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

D S Charney

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704956%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

J H Krystal

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704956%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 March 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704956%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

published in

Biological Psychiatry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704956%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704956%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704956%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

450-462

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704956%20AND%20SRC:MED&resulttype=core&format=json

Effects of the PCP analog dizocilpine on sensory gating: potential relevance to clinical subtypes of schizophrenia.

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900133-X

Serotonin and dopamine metabolites in brain regions and cerebrospinal fluid of a primate species: effects of ketamine and fluphenazine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900133-X

Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900133-X

The glycine/NMDA receptor antagonist, L-701,324 reverses isolation-induced deficits in prepulse inhibition in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900133-X

Two glycine transporter variants with distinct localization in the CNS and peripheral tissues are encoded by a common gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900133-X

The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900133-X

The origin and turnover of D-serine in brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900133-X

Actions of D-cycloserine at the N-methyl-D-aspartate-associated glycine receptor site in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900133-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900133-X

Modulation of excitatory synaptic transmission by glycine and zinc in cultures of mouse hippocampal neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900133-X

Competitive NMDA and strychnine-insensitive glycine-site antagonists disrupt prepulse inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900133-X

Comparative effect of transient global ischemia on extracellular levels of glutamate, glycine, and gamma-aminobutyric acid in vulnerable and nonvulnerable brain regions in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900133-X

A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900133-X

Startle gating deficits occur across prepulse intensities in schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900133-X

Competitive antagonists and partial agonists at the glycine modulatory site of the mouse N-methyl-D-aspartate receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900133-X

Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900133-X

Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900133-X

Cerebrospinal fluid pharmacokinetics of the antituberculosis drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900133-X

D-cycloserine: a ligand for the N-methyl-D-aspartate coupled glycine receptor has partial agonist characteristics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900133-X

Depletion of cerebral D-serine in non-ketotic hyperglycinemia: possible involvement of glycine cleavage system in control of endogenous D-serine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900133-X

Glycyldodecylamide, a phencyclidine behavioral antagonist, blocks cortical glycine uptake: implications for schizophrenia and substance abuse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900133-X

Reversal of phencyclidine-induced hyperactivity by glycine and the glycine uptake inhibitor glycyldodecylamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900133-X

Amelioration of negative symptoms in schizophrenia by glycine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900133-X

Glycine potentiates the NMDA response in cultured mouse brain neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900133-X

Glycine stimulated growth hormone release in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900133-X

Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900133-X

Evidence of acoustic startle hyperreflexia in recently detoxified early onset male alcoholics: modulation by yohimbine and m-chlorophenylpiperazine (mCPP).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900133-X

Preliminary investigation of high-dose oral glycine on serum levels and negative symptoms in schizophrenia: an open-label trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900133-X

In vivo determination of extracellular concentration of amino acids in the rat hippocampus. A method based on brain dialysis and computerized analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900133-X

Characterization of a [3H]glycine recognition site as a modulatory site of the N-methyl-D-aspartate receptor complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900133-X

The treatment of isovaleric acidemia with glycine supplement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900133-X

Neutral amino acid uptake by the isolated perfused sheep choroid plexus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900133-X

Evidence for separate systems for the transport of neutral and basic amino acids across the blood-brain barrier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900133-X

Intracerebral microdialysis of extracellular amino acids in the human epileptic focus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900133-X

Cloning and expression of a glycine transporter reveal colocalization with NMDA receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900133-X

In vivo evidence for the link between L- and D-serine metabolism in rat cerebral cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900133-X

Glycine is a coagonist at the NMDA receptor/channel complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900133-X

Pathways of serine and glycine metabolism in primary culture of ovine fetal hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900133-X

Therapeutic trial with glycine in myoclonus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900133-X

Pharmacological characteristics of cyclic homologues of glycine at the N-methyl-D-aspartate receptor-associated glycine site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900133-X

Effect of the glycine/NMDA receptor partial agonist, D-cycloserine, on seizure threshold and some pharmacodynamic effects of MK-801 in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900133-X

10.1016/S0006-3223(99)00133-X

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10704956%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference